Using advanced MRI to track breast cancer treatment response
Multinuclear MRI to Monitor Breast Cancer Therapy
['FUNDING_R01'] · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · NIH-10985009
This study is looking at a new kind of MRI to help doctors see how well breast cancer treatment is working, especially for patients getting chemotherapy before surgery, so they can make better decisions about their care.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NEW YORK UNIVERSITY SCHOOL OF MEDICINE (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-10985009 on ClinicalTrials.gov |
What this research studies
This research focuses on improving the monitoring of breast cancer treatment by using a new type of MRI called multinuclear MRI. It aims to identify patients who are not responding well to neoadjuvant chemotherapy, which is often used to shrink tumors before surgery. By measuring changes in cellular conditions, such as sodium levels and cell volume, the study seeks to provide earlier and more accurate assessments of treatment effectiveness. This could help doctors tailor therapies more effectively for individual patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with locally advanced invasive breast cancer who are undergoing neoadjuvant chemotherapy.
Not a fit: Patients who are not undergoing neoadjuvant chemotherapy or those with early-stage breast cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective treatment plans for breast cancer patients, reducing unnecessary side effects from ineffective therapies.
How similar studies have performed: Other research has shown promise in using advanced imaging techniques to monitor cancer treatment, suggesting that this approach could be effective.
Where this research is happening
NEW YORK, UNITED STATES
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MADELIN, GUILLAUME — NEW YORK UNIVERSITY SCHOOL OF MEDICINE
- Study coordinator: MADELIN, GUILLAUME
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.